Loop Health Review
Best for: Users wanting a peptide/wellness membership with GLP-1s as one of several offerings rather than the headline product.
Loop Health (loop.health) is a US-based telehealth membership platform offering peptide therapies, health coaching, and compounded GLP-1 protocols (semaglutide and tirzepatide) under its 'Loop Lean' program. Membership starts at $79/mo or $1,500/yr (includes a stated $180/mo 'research credit'). Compounds are 'prescribed and billed separately by the pharmacy' — drug pricing is not disclosed on the public site. The platform also offers NAD+, Sermorelin, hair/skin peptides, sexual wellness peptides, bloodwork, and weekly live educational sessions, making it multi-product rather than GLP-1-only. Site states 'Available in select U.S. states where our provider partners are licensed' and references 'Available in 50 states' for cancellation terms. Loop Health discloses it 'is not a healthcare provider' and connects users with independent licensed providers; founder identified as Stephanie Gambetta. Compounded medication FDA-non-approval disclaimer is published verbatim on site.
Medium confidence · Last verified 2026-05-15 via manual · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Loop Health is a solid telehealth option with balanced features and pricing.
Score Breakdown
Drugs Offered
Loop Health prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| Membership (monthly) | compounded | $79 |
| Membership (annual, includes $180/mo research credit) | compounded | $125 |
✓ Pros
- •Multi-product wellness platform — GLP-1 plus peptides, NAD+, coaching, bloodwork
- •Low membership entry point ($79/mo)
- •Annual plan includes monthly 'research credit' toward compounds
- •Explicit compounded-drug FDA disclaimer on-site
✗ Cons
- •Per-dose GLP-1 drug pricing not transparent on public site (compounds billed separately by pharmacy)
- •States-served list not enumerated — only 'select U.S. states'
- •Platform explicitly 'is not a healthcare provider' — relies on independent provider network
- •No LegitScript number disclosed on homepage
Ready to start with Loop Health?
Starting at $79/month. See current pricing and start your free consultation.
Sources & methodology
Our Loop Health review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Alternatives to Loop Health
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with Loop Health?
Starting at $79/month. See current pricing and start your free consultation.